Daniel A. Lawrence

15.8k citations

215 papers · 13.1k indexed · 2 hit papers · h-index 65

Impact in

Cancer Research top 0.05%
- Protease and Inhibitor Mechanisms
Hematology top 0.1%
- Blood Coagulation and Thrombosis Mechanisms

Papers in

Cancer Research 119
- Protease and Inhibitor Mechanisms 117
Hematology 76
- Blood Coagulation and Thrombosis Mechanisms 76

Co-authors: Steingrimur Stefansson David J. Loskutoff Manuel Yepes David Ginsburg Dudley K. Strickland Maria Sandkvist Jan A. van Mourik Elizabeth Moore
Journals: Journal of Biological Chemistry (41 papers)Journal of Clinical Investigation (10 papers)Blood (8 papers)Journal of Thrombosis and Haemostasis (7 papers)Proceedings of the National Academy of Sciences (5 papers)
Partner nations: United States Sweden Canada

In The Last Decade

Daniel A. Lawrence

205 papers receiving 12.8k citations

Hit Papers

align trajectories log scale

Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients 2021 · 150 citations

Peers

Countries citing papers authored by Daniel A. Lawrence

Since Specialization

Citations

This map shows the geographic impact of Daniel A. Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Lawrence more than expected).

Fields of papers citing papers by Daniel A. Lawrence

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel A. Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Lawrence. The network helps show where Daniel A. Lawrence may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Daniel A. Lawrence, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel A. Lawrence Line = papers co-authored together Daniel A. Lawrence links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	PAI-1 interaction with sortilin-related receptor 1 is required for lung fibrosis JCI Insight ·Thomas H. Sisson, John J. Osterholzer, Lisa Leung, Venkatesha Basrur, Alexey I. Nesvizhskii, 周平轩, Mark Warnock, Daniel Torrente, 松之助愛知, Sergey Gutor, Jeffrey C. Horowitz, Mary Migliorini, Dudley K. Strickland, Kevin K. Kim, Steven K. Huang, Daniel A. Lawrence	2025	0
2	Understanding the Form and Timing of Damage to Archaeological Sites During the Syrian Conflict by Combining Evidence From Remote Sensing With Ground Observation Archaeological Prospection ·M Shimada, نواف عودة سالم الحسبان, 李维福, Daniel A. Lawrence, Graham Philip	2025	0
3	Acinetobacter Baumannii Secreted Protease CpaA Inhibits Factor XII-Mediated Bradykinin Generation and Neutrophil Activation Circulation Research ·Kris M. Blair, Lisa Perrone, Alberto Toscano, Mark Warnock, Basel H. Abuaita, 朱辉建, Sophia Shaqra, Steven H. Marshall, Brigid Wilson, Robert A. Bonomo, Ajay Tambralli, Jason S. Knight, Mary O’Riordan, Daniel A. Lawrence, Evi X. Stavrou, Maria Sandkvist	2025	1
4	The interaction of tPA with NMDAR1 drives neuroinflammation and neurodegeneration in α-synuclein-mediated neurotoxicity Journal of Neuroinflammation ·Daniel Torrente, Enming J. Su, Alí Francisco Citalán‐Madrid, Gerald P. Schielke, Park Jai Koo, Mark Warnock, George B. Vogt, Kris Mann, Flavie Lesept, Annas Aulia Malik, Devdariani A. Z, Erin H. Norris, Denis Vivien, Daniel A. Lawrence	2025	3
5	PDGFRα inhibition reduces myofibroblast expansion in the fibrotic rim and enhances recovery after ischemic stroke Journal of Clinical Investigation ·Chunqiang Feng, Manuel Zeitelhofer, Christina Stefanitsch, Daniel Torrente, Milena Z. Adzemovic, Shrider Abidhatla, Shipla Rudraraju, Sebastian A. Lewandowski, Lars Muhl, Ulf Eriksson, Ingrid Nilsson, Enming J. Su, Daniel A. Lawrence, Linda Fredriksson	2025	0
6	Magnetically powered microwheel thrombolysis of occlusive thrombi in zebrafish Proceedings of the National Academy of Sciences ·Feyisa Dessalegn, Бисенова Марал Аманжаловна, Franco Ambrosio, Isnard Freitas, Yang Liu, Mark Warnock, Daniel A. Lawrence, David W. M. Marr, Keith B. Neeves, Jordan A. Shavit	2024	4
7	Mapping the Use of Artificial Intelligence–Based Image Analysis for Clinical Decision‐Making in Dentistry: A Scoping Review Clinical and Experimental Dental Research ·Wei Chen, Nagaitsev Ng, Jonathan Liu, Parkinson Jt, I. PETRYSHYN, Daniel Tran, Daniel A. Lawrence, Ruedas Me, Nicola Cirillo	2024	4
8	SORL1 is a receptor for tau that promotes tau seeding Journal of Biological Chemistry ·武雄森川, Aurélien Lathuilière, Enming J. Su, Yuyu Song, Daniel Torrente, Youhwa Jo, Deigo Adit Dwi Prasetyo, Eugenia Siteanu, Mary Migliorini, Thomas H. Sisson, Daniel A. Lawrence, Bradley T. Hyman, Dudley K. Strickland	2024	7
9	Defibrotide Therapy for SARS-CoV-2 ARDS CHEST Journal ·David Frame, Паршакова Кристина Алексеевна, Thomas Braun, Mary Maliarik, Thomas H. Sisson, Steven W. Pipe, Daniel A. Lawrence, Paul G. Richardson, Michael Holinstat, Robert C. Hyzy, Daniel Kaul, Kevin Gregg, Vibha N. Lama, Gregory A. Yanik	2022	11
10	Heparin and Arginine Based Plasmin Nanoformulation for Ischemic Stroke Therapy International Journal of Molecular Sciences ·和弘土屋, Kang In-Kyu, Netanel Korin, Daniel A. Lawrence, Enming J. Su, Mathumai Kanapathipillai	2021	13
11	Deep mutational scanning of the plasminogen activator inhibitor-1 functional landscape Scientific Reports ·최재영, 賢一堤, Andrew Yee, Colin A. Kretz, Matthew L. Holding, David Siemieniak, Daniel A. Lawrence, David Ginsburg	2021	11
12	Pharmacological targeting of the PDGF-CC signaling pathway for blood–brain barrier restoration in neurological disorders Pharmacology & Therapeutics ·Sebastian A. Lewandowski, Linda Fredriksson, Daniel A. Lawrence, Ulf Eriksson	2016	37
13	Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblasts Laboratory Investigation ·Jianyong Zhong, Haichun Yang, Valentina Kon, Agnes B. Fogo, Daniel A. Lawrence, Ji Ma	2014	22
14	Helix-B peptide of erythropoietin could be used as pharmacotherapy in critical limb ischaemia UCL Discovery (University College London) ·C Yesou, M Epstein, Shiwen Xu, Hetalben Patel, Sadasivam Selvakumar, Daniel A. Lawrence, Dietmar Abraham, Daryll Baker	2011	1
15	Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis Journal of Vascular Surgery ·José A. Díaz, Romali. Noor Suraya, Diana Farris, Angela E. Hawley, Shirley K. Wrobleski, Daniel D. Myers, Peter K. Henke, Daniel A. Lawrence, Thomas W. Wakefield	2011	33
16	Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39 Journal of Clinical Investigation ·Matthew C. Hyman, Danica Petrovic‐Djergovic, Scott Visovatti, Hui Liao, Sunitha Yanamadala, Diane Bouïs, Enming J. Su, Daniel A. Lawrence, M. Johan Broekman, Aaron J. Marcus, David J. Pinsky	2009	98
17	Tissue plasminogen activator-mediated PDGF signaling and neurovascular coupling in stroke Journal of Thrombosis and Haemostasis ·Enming J. Su, Linda Fredriksson, Gerald P. Schielke, Ulf Eriksson, Daniel A. Lawrence	2009	30
18	Dual Role for Plasminogen Activator Inhibitor Type 1 as Soluble and as Matricellular Regulator of Epithelial Alveolar Cell Wound Healing American Journal Of Pathology ·Наталія Петруляк, Stéphane Galiacy, Michel Malo, Christophe Guignabert, Daniel A. Lawrence, Marie‐Pia d’Ortho, Georgia Barlovatz‐Meimon	2006	41
19	Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent Journal of Clinical Investigation ·Manuel Yepes, Maria Sandkvist, Timothy A. Coleman, Elizabeth Moore, Emily Finley, David Mitola, Thomas Bugge, Daniel A. Lawrence	2002	111
20	The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion Structure ·Allan M. Sharp, Penelope E. Stein, N.S. Pannu, Robin W. Carrell, Mitchell B. Berkenpas, David Ginsburg, Daniel A. Lawrence, Randy J. Read	1999	142

About Daniel A. Lawrence

Daniel A. Lawrence is a scholar working on Cancer Research, Hematology, Immunology and Allergy, Internal Medicine and Neurology, having authored 215 papers that have together received 13.1k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (117 papers), Blood Coagulation and Thrombosis Mechanisms (76 papers), Cell Adhesion Molecules Research (30 papers), Acute Ischemic Stroke Management (21 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (17 papers), Blood properties and coagulation (15 papers), Signaling Pathways in Disease (14 papers) and S100 Proteins and Annexins (12 papers). The work is most often cited by research in Cancer Research (6.5k citations), Hematology (4.3k citations), Immunology and Allergy (1.7k citations), Neurology (1.0k citations) and Internal Medicine (463 citations). Daniel A. Lawrence has collaborated with scholars based in United States, Sweden and Canada. Frequent co-authors include Steingrimur Stefansson, David J. Loskutoff, Manuel Yepes, David Ginsburg, Dudley K. Strickland, Maria Sandkvist, Jan A. van Mourik, Elizabeth Moore, Thomas H. Bugge and Tor Ny. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation, Blood, Journal of Thrombosis and Haemostasis and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact